RUNX3决定胰腺导管腺癌的疾病行为。
RUNX3 defines disease behavior in pancreatic ductal adenocarcinoma.
作者信息
Whittle Martin C, Hingorani Sunil R
机构信息
Clinical Research Division , Seattle, WA.
Clinical Research Division, Seattle, WA; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Division of Medical Oncology, University of Washington School of Medicine, Seattle, WA.
出版信息
Mol Cell Oncol. 2015 Jul 29;3(2):e1076588. doi: 10.1080/23723556.2015.1076588. eCollection 2016 Mar.
Abstract
Runt-related transcription factor 3 (RUNX3) functions downstream of transforming growth factor beta (TGFβ) and plays dual roles in pancreas cancer by both suppressing (by inhibiting proliferation) and promoting (by enhancing migratory and metastatic capacity) disease progression. Consideration of the contextual regulation of RUNX3 together with its myriad downstream effects may help improve clinical outcomes for pancreas cancer patients.
摘要
runt相关转录因子3（RUNX3）在转化生长因子β（TGFβ）下游发挥作用，通过抑制（抑制增殖）和促进（增强迁移和转移能力）疾病进展在胰腺癌中发挥双重作用。考虑RUNX3的上下文调节及其众多下游效应可能有助于改善胰腺癌患者的临床结局。
相似文献
1
RUNX3 defines disease behavior in pancreatic ductal adenocarcinoma.RUNX3决定胰腺导管腺癌的疾病行为。
Mol Cell Oncol. 2015 Jul 29;3(2):e1076588. doi: 10.1080/23723556.2015.1076588. eCollection 2016 Mar.
2
Combination immunohistochemistry for SMAD4 and Runt-related transcription factor 3 may identify a favorable prognostic subgroup of pancreatic ductal adenocarcinomas.SMAD4和Runt相关转录因子3的联合免疫组化可能识别出胰腺导管腺癌的一个预后良好的亚组。
Oncotarget. 2017 Sep 11;8(44):76699-76711. doi: 10.18632/oncotarget.20815. eCollection 2017 Sep 29.
3
RUNX3 expression in primary and metastatic pancreatic cancer.RUNX3在原发性和转移性胰腺癌中的表达。
J Clin Pathol. 2004 Mar;57(3):294-9. doi: 10.1136/jcp.2003.013011.
4
Glycemic Variability Promotes Both Local Invasion and Metastatic Colonization by Pancreatic Ductal Adenocarcinoma.血糖变异性促进胰腺导管腺癌的局部侵袭和转移定植。
Cell Mol Gastroenterol Hepatol. 2018 Jul 26;6(4):429-449. doi: 10.1016/j.jcmgh.2018.07.003. eCollection 2018.
5
RUNX3 Modulates Metastatic Potential in Pancreatic Ductal Adenocarcinoma.RUNX3 调控胰腺导管腺癌的转移潜能。
Cancer Discov. 2015 Jul;5(7):OF27. doi: 10.1158/2159-8290.CD-RW2015-103. Epub 2015 Jun 4.
6
Negative control of TRAIL-R1 signaling by transforming growth factor β1 in pancreatic tumor cells involves Smad-dependent down regulation of TRAIL-R1.转化生长因子β1对胰腺肿瘤细胞中TRAIL-R1信号的负调控涉及Smad依赖的TRAIL-R1下调。
Cell Signal. 2016 Nov;28(11):1652-62. doi: 10.1016/j.cellsig.2016.07.016. Epub 2016 Aug 1.
7
Runx3 and Cell Fate Decisions in Pancreas Cancer.Runx3与胰腺癌中的细胞命运决定
Adv Exp Med Biol. 2017;962:333-352. doi: 10.1007/978-981-10-3233-2_21.
8
The emerging role of RUNX3 in cancer metastasis (Review).RUNX3在癌症转移中的新作用（综述）。
Oncol Rep. 2016 Mar;35(3):1227-36. doi: 10.3892/or.2015.4515. Epub 2015 Dec 24.
9
Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines.人类胆管和胰腺癌细胞系中RUNX3基因表达频繁缺失。
Oncogene. 2004 Mar 25;23(13):2401-7. doi: 10.1038/sj.onc.1207395.
10
RUNX3 inhibits cell proliferation and induces apoptosis by reinstating transforming growth factor beta responsiveness in esophageal adenocarcinoma cells.RUNX3通过恢复食管腺癌细胞中转化生长因子β的反应性来抑制细胞增殖并诱导细胞凋亡。
Surgery. 2004 Aug;136(2):310-6. doi: 10.1016/j.surg.2004.05.005.
引用本文的文献
1
Flaming the fight against cancer cells: the role of microRNA-93.点燃对抗癌细胞之战：微小RNA-93的作用
Cancer Cell Int. 2020 Jun 29;20:277. doi: 10.1186/s12935-020-01349-x. eCollection 2020.
2
RUNX family: Oncogenes or tumor suppressors (Review).RUNX 家族：癌基因还是抑癌基因（综述）。
Oncol Rep. 2019 Jul;42(1):3-19. doi: 10.3892/or.2019.7149. Epub 2019 May 6.
3
Circulating Tumor and Invasive Cell Gene Expression Profile Predicts Treatment Response and Survival in Pancreatic Adenocarcinoma.循环肿瘤细胞和侵袭性细胞基因表达谱可预测胰腺腺癌的治疗反应和生存情况。
Cancers (Basel). 2018 Nov 24;10(12):467. doi: 10.3390/cancers10120467.
4
Loss of expression rather than cytoplasmic mislocalization of RUNX3 predicts worse outcome in non-small cell lung cancer.RUNX3表达缺失而非细胞质定位错误预示着非小细胞肺癌的预后更差。
Oncol Lett. 2018 Apr;15(4):5043-5055. doi: 10.3892/ol.2018.7993. Epub 2018 Feb 8.
5
Paradoxical enhancement of leukemogenesis in acute myeloid leukemia with moderately attenuated RUNX1 expressions.RUNX1表达适度减弱的急性髓系白血病中白血病发生的矛盾性增强。
Blood Adv. 2017 Aug 8;1(18):1440-1451. doi: 10.1182/bloodadvances.2017007591.
6
RUNX1 promote invasiveness in pancreatic ductal adenocarcinoma through regulating miR-93.RUNX1通过调控miR-93促进胰腺导管腺癌的侵袭性。
Oncotarget. 2017 Aug 24;8(59):99567-99579. doi: 10.18632/oncotarget.20433. eCollection 2017 Nov 21.
7
Combination immunohistochemistry for SMAD4 and Runt-related transcription factor 3 may identify a favorable prognostic subgroup of pancreatic ductal adenocarcinomas.SMAD4和Runt相关转录因子3的联合免疫组化可能识别出胰腺导管腺癌的一个预后良好的亚组。
Oncotarget. 2017 Sep 11;8(44):76699-76711. doi: 10.18632/oncotarget.20815. eCollection 2017 Sep 29.
本文引用的文献
1
RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma.RUNX3调控胰腺导管腺癌中的转移开关。
Cell. 2015 Jun 4;161(6):1345-60. doi: 10.1016/j.cell.2015.04.048. Epub 2015 May 21.
2
Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies.胰腺癌的计算模型揭示了转移的动力学，提示了最佳的治疗策略。
Cell. 2012 Jan 20;148(1-2):362-75. doi: 10.1016/j.cell.2011.11.060.
3
Cyclin D as a therapeutic target in cancer.细胞周期蛋白 D 作为癌症治疗靶点。
Nat Rev Cancer. 2011 Jul 7;11(8):558-72. doi: 10.1038/nrc3090.
4
RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD.RUNX3通过与转化生长因子β激活的SMAD协同诱导p21（WAF1/Cip1）表达来抑制胃上皮细胞生长。
Mol Cell Biol. 2005 Sep;25(18):8097-107. doi: 10.1128/MCB.25.18.8097-8107.2005.
5
Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice.Trp53R172H和KrasG12D共同作用，促进小鼠染色体不稳定和广泛转移的胰腺导管腺癌。
Cancer Cell. 2005 May;7(5):469-83. doi: 10.1016/j.ccr.2005.04.023.
6
Tumor suppressor activity of RUNX3.RUNX3的肿瘤抑制活性。
Oncogene. 2004 May 24;23(24):4336-40. doi: 10.1038/sj.onc.1207286.
7
Genetic progression in the pancreatic ducts.胰腺导管中的基因进展。
Am J Pathol. 2000 Jun;156(6):1821-5. doi: 10.1016/S0002-9440(10)65054-7.
8
DNA content and other factors associated with ten-year survival after resection of pancreatic carcinoma.胰腺癌切除术后的DNA含量及与十年生存率相关的其他因素。
J Surg Oncol. 1998 Mar;67(3):151-9. doi: 10.1002/(sici)1096-9098(199803)67:3<151::aid-jso2>3.0.co;2-8.
Zotero 插件